Rejoining the USF infectious disease faculty in 2002 was, for Dr. Oehler, in several ways, a homecoming. A Tampa native, he has long had an affiliation with the University of South Florida since taking math and science summer courses as a high school student in the early 1980's. After receiving his M.D. at the USF College of Medicine in 1992, Dr. Oehler completed his Internship and Residency at Emory University in 1995. He then returned to USF to train in Infectious Diseases. In 1997, a private practice opportunity in Huntsville, AL, beckoned, and he relocated to northern Alabama. He practiced there successfully for 5 years, but still felt a longing to return to his hometown and its growing and ever more successful university. The opportunity to join the clinical faculty at the James A. Haley Veterans Hospital, the busiest VA in the country, came in 2002. He currently serves as an attending in infectious diseases at the VA as well as at the USF Medical Clinics, Moffitt Cancer Center, Tampa General Hospital, Shriner's Hospital, and Kindred Hospital, all in Tampa. Since his return, Dr. Oehler has also been instrumental in the development of division educational programs for faculty and fellows. He has received national recognition for his research in infections in returning soldiers. He was also the first clinician in the Tampa Bay area to document the presence of Community-acquired MRSA strains in a local hospital. He has appeared in several local media news stories. He enjoys speaking on numerous subjects, including emerging infectious diseases, Methicillin-Resistent Staphylococcus Aureus infections, and infections of the diabetic foot. Dr. Oehler is the founder and webmaster of IDPodcasts.net. Dr. Oehler is married and has two children.

Methicillin-Resistant Staph aureus infections

Emerging Infectious Diseases/Influenza

Infections in the Immunocompromised Host

Human Immunodeficiency Virus Infections

Bone and Joint Infections

Wound Infections/Diabetic Foot

Mycobacterial infections

(State/Federal – Coinvestigator)

Toney JF, Gompf SG, Oehler RL. VA Cooperative grant CSP #403 Shingles Prevention Study. Protocol CSP403. Dates: 2002-present

(Pharmaceutical -- Coinvestigator)

Toney JF, Bergan GA, Nadler JP, Dominguez E, Oehler RL, and Poblete SJ. A Randomized, Double Blind Study of Safety, Virologic and Immunological Effects of Stavudine plus 3TC in HIV-Infected Subjects Following at least Six (6) Months of Zidovudine Therapy. Bristol-Myers Squibb. 1996

Toney JF, Bergan GA, Nadler JP, Dominguez E, Oehler RL, Poblete SJ, and Seeley P. An Open-Label, Multicenter, Safety and Efficacy Study of 5% Topical Imiquimod Cream in the Treatment of Visible, External Genital/Perianal Warts in Male and Female Patients. 3M. 1998

Toney JF, Bergan GA, Nadler JP, Dominguez E, Oehler RL, Poblete SJ, and Seeley P. An Open Comparitive Multicenter Study of Intravenous Itraconazole followed by Itraconazole Oral Solution versus Intravenous Fluconazole followed by Oral Fluconazole Tablets in the Treatment of Candidemia in Non-Neutropenic patients. Janssen. 1996.

Toney JF, Bergan GA, Nadler JP, Dominguez E, Oehler RL, Poblete SJ, and Seeley P. A Phase III, Double Blinded, Placebo-Controlled Trial of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor (rhu-GM-CSF) in Patients with Advanced HIV Disease. Immunex. 1996.

Gompf SG, Oehler, RL, Toney JF, Nadler JP. A Randomized, Multicenter, Open Label, Phase IV Study Evaluating the Efficacy and Safety of 16-Week Versus 24-Week Treatment with PEGASYS ® in Combination with Copegus® in Interferon-naïve Patients with Chronic Hepatitis C Genotype 2 or 3 Virus Infection. Roche. Protocol NV17317. Dates: 2003-present

Toney JF, Gompf SG, Oehler RL, Cutolo EP, Lezama J. Intravenous ARBELIC (AMI-6424) for Uncomplicated Staphylococcus Aureus Bacteremia (Phase II Study). Theravance. Protocol TD-6424. Dates: 2003-present

Greene JN, Oehler RL, Gompf SG. 045-00 A multicenter, open, non-comparative study to estimate the safety, tolerability, and efficacy of caspofungin acetate in the treatment of adults with invasive Candida infections, Merck. Protocol 045-00 2005, (5% effort)

Greene JN, Oehler RL, Gompf SG. A randomized controlled trial of posaconazole (SCH 56592) vs. standard azole therapy for the prevention of invasive fungal infections among high-risk neutropenic patients, Schering Plough. Protocol P01899, 2005, (5% effort)

Grants:

Hemophilia of Georgia. Grant# 6123-412-L0
Duties: Patient Care. Staff weekly Clinic. Administrative duties
Dates: 2002-present

Burdette SD, Herchline TE, Oehler R. Practicing Medicine in a Technological Age: Using Smartphones in Clinical Practice. CID. 47: 117-122, 2008.

Mastorides SM, Oehler RL, Greene JN, Sinnott JT, et al. Detection of Airborne Mycobacterium tuberculosis Using Micropore Membrane Air Sampling and Polymerase Chain Reaction. Chest. 115(1): 19-25, 1999 Jan.

Oehler RL, Lorenzo, N. Severe Acute Respiratory Syndrome. Emedicine.com (electronic publication), July 28, 2003. Revised, 2004, 2005.

Cooper CD, Oehler RL, Greene JN, Sandin R. A Gardnener Susceptible to Lymphangitis. Infections in Medicine. 21(2):66, 2004.

Clum S, Cooks A, Lezama JL, Oehler RL, Cutolo EP. Challenging Cases in Infectious Diseases: Abdominal and Scrotal Pain. Infect Med. 21:276-283, 2004 Jun.

Oehler RL, Elko LM, Gompf SG. Acute Graft Thrombosis Secondary to Listeria Bacteremia: A Case Report and Review of the Literature. Infect Dis Clin Pract. 2:345-9. 2004 Nov

Oehler R. A Man with Fevers and New Onset Seizures. Infections in Medicine. 119-22. 2005 Mar.

Gompf S, Oehler R. Adenoviruses. Emedicine.com (electronic publication), (Revision) 2005.

Tan, M, Oehler RL. Lower Extremity Cellulitis and Bacteremia with Herbaspirillum seropedicae associated with Aquatic Exposure in a Patient with Cirrhosis. Infect Dis Clin Pract. 13:277-9, 2005.

Search Google Scholar for Publications by Dr. Oehler